Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial LDL-size and subclasses in patients with type-2 diabetes.
- Autori: Berneis, K; Rizzo, M; Stettler, C; Chappuis, B; Diem, P; Christ, ER
- Anno di pubblicazione: 2008
- Tipologia: Abstract in rivista (Abstract in rivista)
- OA Link: http://hdl.handle.net/10447/76533